Artiva Biotherapeutics, Inc. ARTV Preferred Stock, Shares Authorized
Preferred Stock, Shares Authorized at other companies
Other financials
Where this comes from
Reported directly by Artiva Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.
The source filing: Artiva Biotherapeutics, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:12 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338029
Under the Amended and Restated Certificate of Incorporation dated July 22, 2024, the Company had a total of 710,000,000 shares of capital stock authorized for issuance, consisting of 700,000,000 shares of common stock, par value of $0.0001 per share, and 10,000,000 shares of preferred stock, par value of $0.0001 per share. Additionally, the Company has authorized 84,556 shares reserved under the terms specified as part of the Company’s Pledge 1% Movement commitment, in support of its corporate social responsibility and philanthropic pursuits.
Item 1. Financial Statements
FAQ
- What is Artiva Biotherapeutics, Inc.'s preferred stock, shares authorized?
- Artiva Biotherapeutics, Inc. (ARTV) reported preferred stock, shares authorized of $10M in Q3 2024.
- What does preferred stock, shares authorized mean?
- Preferred Stock, Shares Authorized
Ask your AI about Artiva Biotherapeutics, Inc.'s preferred stock, shares authorized.
Connect your AI assistant and compare it to peers, right in your chat.
